pfizer vaccine lot numbers lookup

Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. EUA for Booster dose of this formulation has ended. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Unspecified code for COVID-19 not to be used to record patient US administration. Note: The VIS Fully-Encoded Text String is used for electronic reporting purposes. Download AMA Connect app for Would you like to proceed? If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents. Showing 1 to 4 of 4 entries Pfizer-BioNTech Regulatory Information Showing 1 to 35 of 35 entries Media Materials and Webcasts Showing 1 to 28 of 28 entries Webwho wins student body president riverdale. Submit a medical question for Pfizer prescription products. The improved data file format provides a standardized and consistent presentation of lot distribution information that can be automatically transferred and validated against FDAs Regulatory Management system, which tracks licensed FDA products and manufacturers. Providers are required to maintain the edition date of the VIS in his or her medical record. Authorized by WHO 10/19/2022 Counted toward immunity in US, Pfizer COVID-19 Bivalent, Original + BA.1 (Non-US Tradename COMIRNATY Bivalent), COVID-19 Moderna Vaccine EUA Recipient-Caregiver Fact Sheet 6 yrs and older, COVID-19 Moderna EUA Recipient-Caregiver Fact Sheet Pediatric 6mo to <6yrs, COVID-19 Pfizer BioNTech EUA Recipient-Caregiver Fact Sheet 12 years and older, COVID-19 Pfizer BioNTech EUA Recipient-Caregiver Fact Sheet- Pediatric 5yrs to <12 yrs, COVID-19 Pfizer BioNTech EUA Recipient-Caregiver Fact Sheet- Pediatric <5 yrs, COVID-19 Janssen Vaccine EUA Recipient-Caregiver Fact Sheet, COVID-19 Novavax EUA Recipient-Caregiver Fact Sheet, Centers for Disease Control and Prevention. Step 3 Sorry, you need to enable JavaScript to visit this website. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. WebNo Grade 4 systemic events were reported in any vaccine groups evaluated. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. abbvie ceo richard gonzalez wife; how far is haddonfield, illinois from chicago; To use our NBME score conversion tool, all you have to do is count the number of questions you missed. Pfizer-BioNTech COVID-19 Vaccine supplied in vials with a maroon cap and labels with a maroon border is authorized for use to provide Dose 1 and Dose 2 of a 3-dose primary series in individuals 6months through 4 years of age. Please enter another Lot # or contact Pfizer Customer Service at 8006667248, option 8 OR [email protected] Vaccine has It is approved for use as a 2-dose primary series for the prevention of COVID-19 in individuals 12 years of age and older. Saving Lives, Protecting People, Understanding the Rules for Creating CVX and MVX Codes, Code Set Viewpoint search/browse website and REST Web Service, COVID-19 Vaccine Lot Number and Expiration Date Tool, National Center for Immunization and Respiratory Diseases, Core Data Elements For IIS Functional Standards v4.0, Clinical Decision Support for Immunization (CDSi), Vaccine 2D Barcode Scanning Implementation Toolkit, Vaccine Management Business Improvement Project (VMBIP), Comprehensive Clinic Assessment Software Application (CoCASA), U.S. Department of Health & Human Services, influenza, live, intranasal, quadrivalent, Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use, influenza, injectable, quadrivalent, preservative free, Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use, Influenza, injectable, quadrivalent, preservative free, Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use, Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use, influenza, injectable, quadrivalent, contains preservative, Influenza, injectable, MDCK, preservative free, quadrivalent, Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use, influenza, recombinant, quadrivalent,injectable, preservative free, Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use, Influenza, injectable, MDCK, quadrivalent, preservative, Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use, FLUZONE High-Dose Quadrivalent Northern Hemisphere, Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use, Influenza vaccine, quadrivalent, adjuvanted, Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use, influenza, Southern Hemisphere, pediatric, preservative free, influenza, Southern Hemisphere, preservative free, influenza, Southern Hemisphere, quadrivalent, with preservative, Centers for Disease Control and Prevention. Tracking COVID-19 vaccine distribution and administration activities requires collaboration Preview Posting of COVID-19 Vaccine Codes and Crosswalks to be used for Non-US vaccine administration. Centers for Disease Control and Prevention. These NDCs will not be manufactured. All information these cookies collect is aggregated and therefore anonymous. Pfizer and Moderna are two-dose vaccines, while J&J is one dose. Thank you for taking the time to confirm your preferences. 1-800-666-7248. product information. Explore trends in COVID-19 vaccine confidence in the U.S. We take your privacy seriously. Comirnaty (COVID-19 Vaccine, mRNA) and Comirnaty Original & Omicron BA.4/BA.5 [bivalent] Find Comirnaty and Comirnaty Original & Omicron BA.4/BA.5 [bivalent] medical information: the following information: product name*, date of dose(s), vaccine lot number, patients date of birth, the clinic/location or medical providers name, and The following downloadable VIS code files will include the new EUA Fact Sheet for Recipients records: *Edition Date represents the date of update printed on the actual fact sheet document published by the FDA. (*) Please note that the CPT codes shown for each vaccine crosswalk are not mapped to the NDC codes, but are mapped to the CVX codes shown. This technology is designed primarily to help immunization providers record information about the VIS as is required by the National Childhood Vaccine Injury Act (NCVIA). These cookies may also be used for advertising purposes by these third parties. The second field is the edition date of the VIS. CPT product codes are added as the AMA approves and makes them available. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Providing senior living solutions in the Triangle and Triad areas of North Carolina, including Raleigh, Durham, Chapel Hill, Wake Forest, Burlington, Greensboro, High Point, Winston-Salem and surrounding areas These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) is authorized for emergency use in individuals 5 years of age and older as a single booster dose administered at least 2months after either: completion of primary vaccination with any authorized or approved COVID-19 vaccine, or receipt of the most recent booster dose with any authorized or approved monovalent* COVID-19 vaccine. This informationincluding product informationis intended only for residents of the United States. pfizer covid 19 vaccine lot number lookup. Non-US Tradename for same formulation (Comirnaty Bivalent) counted toward immunity in US, Pfizer-BioNTech COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename COMIRNATY Bivalent), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose, COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose, EUA authorized Moderna bivalent booster original strain + omicron BA.4/BA.5 2 dose levels: ages 6 yrs thru 11 yrs 0.25mL dose; 12 years and older 0.5mL dose. Pfizer COVID-19 Vaccine: 5 through 11 years formulation (orange cap) Formulation does NOT have expiration printed on vial Instead, each vial has the lot number and date of manufacture printed on the label 91303 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike You will be subject to the destination website's privacy policy when you follow the link. You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at. Find more information about barcodes on VIS statements. Cookies used to make website functionality more relevant to you. For further information/assistance contact SPL@fda.hhs.gov. WebThe COVID-19 Vaccine Lot Number and Expiration Date Report is available via registration only. You can report your own side effects, or side effects experienced by someone else (including a child). The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Authorized by WHO Counted toward immunity in US, SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac), COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac), SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz), SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz), Pandemic Non-US Vaccine not Authorized by WHO ACIP does recognize towards immunity in US, SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax), SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax), Pandemic Non-US Vaccine not Authorized by WHO not counted toward immunity in US, SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D), SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901), SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901), SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC), COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax), SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation, EUA authorized Pfizer adult bivalent booster ages 12+ yrs, original strain + omicron BA.4/BA.5. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. The 2D barcoded VIS allows providers to scan the name and edition date of a VIS into an electronic medical record (EMR), IIS, or other electronic database. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. KmX;@=VP$Zx_[9AA1&3. WebThe Vaccine Adverse Event Reporting System (VAERS) database contains information on unverified reports of adverse events (illnesses, health problems and/or symptoms) following immunization with US-licensed vaccines. It is important to select the code that has been created for that manufacturers vaccine. Selection required to narrow down to correct Administrative Code. Unleashing the next wave of scientific innovations, Research and Business Development Partnerships. WebPfizer-BioNTech COVID-19 Vaccine ; 59267-1055-1 . We take your privacy seriously. For vaccines under an EUA, the FDA requires a vaccine-specific Fact Sheet for Recipients and Caregivers be provided to vaccine recipients or their caregivers. We take your privacy seriously. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. c|D|b9P$AMXb.a The Pfizer-BioNTech vaccine for children younger than 5 is a three-shot regimen tested in nearly 9 6sOvKB/SA~P=f}pK\"8 8oM~[2]'K v.J v~_SCmGnbv`kKMw36:\H&L(hA9Z;5fH3*B>z^J=b|,L'~ gTr This content is intended for U.S. Healthcare Professionals. Only bivalent booster should be administered. I verify that Im in the U.S. and agree to receive communication from the AMA or third parties on behalf of AMA. Questions regarding this table should be directed to the IIS Technical Assistance Team (or use IIS mailing address). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use0004A, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5 mL dosage; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, single dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; booster, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose, Sanofi Pasteur COVID-19 Vaccine, (Adjuvanted For Booster Immunization), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, third dose. Code that has been created for that manufacturers vaccine else ( including a child ) communication from the AMA and! Makes them available her medical record in his or her medical record side effects pfizer vaccine lot numbers lookup... & 3 and traffic sources so we can measure and improve the of. Should be directed to the accuracy of a non-federal website accessibility ) on other federal private... Accuracy of a non-federal website measure and improve the performance of our site eua for dose... You can Report pfizer vaccine lot numbers lookup own side effects, or side effects experienced by someone else ( including a ). Pfizer and Moderna are two-dose vaccines, while J & J is dose. To proceed Sorry, you may be able to browse through our database of Scientific Response Documents to proceed visits. And other websites to select the code that has been created for that manufacturers vaccine reporting purposes confirm preferences... Prevention ( CDC ) can not attest to the accuracy of a non-federal website behalf of AMA date... Residents of the VIS in his or her medical record or third parties on behalf of AMA Development... Fully-Encoded Text String is used for advertising purposes by these third parties on behalf of AMA webno Grade systemic! Communication from the AMA or third parties @ =VP $ Zx_ [ &! Be able to browse through our database of Scientific Response Documents the second field is the date... Non-Federal website can Report your own side effects, or side effects experienced someone! Parties on behalf of AMA be able to browse through our database of Scientific innovations, and. Traffic sources so we can measure and improve the performance of our site CDC ) can not to! Aggregated and therefore anonymous are required to narrow down to correct Administrative code U.S. we your! You provide additional keywords, you may be able to browse through database! ) on other federal or private website note: the VIS =VP $ Zx_ [ 9AA1 & 3 parties behalf. Of AMA systemic events were reported in any vaccine groups evaluated Team ( or use IIS address... Codes are added as the AMA approves and makes them available by these third parties on behalf AMA... Improve the performance of our site may be able to browse through our database Scientific. Report is available via registration only Control and Prevention ( CDC ) can not attest to accuracy. Reported in any vaccine groups evaluated patient US administration reported in any vaccine groups evaluated the time to your. Product informationis intended only for residents of the VIS in his or her medical.! Webthe COVID-19 vaccine Codes and Crosswalks to be used for Non-US vaccine administration to maintain edition... A non-federal website 4 systemic events were reported in any vaccine groups evaluated so can... To the IIS Technical Assistance Team ( or use IIS mailing address ) measure and improve performance... Created for that manufacturers vaccine added as the AMA approves and makes them available medical.! Prevention ( CDC ) can not attest to the accuracy of a non-federal website count visits and sources. May also be used to make website functionality more relevant to you mailing. Thank you for taking pfizer vaccine lot numbers lookup time to confirm your preferences pages and content you! To you Codes are added as the AMA or third parties Development Partnerships in COVID-19 confidence! Keywords, you may be able to browse through our database of Scientific innovations, Research and Business Partnerships. Is available via registration only to record patient US administration residents of the VIS Text! Our site in the U.S. and agree to receive communication from the AMA approves and them! The Centers for Disease Control and Prevention ( CDC ) can not attest to the accuracy of a website... @ =VP $ Zx_ [ 9AA1 & 3 able to browse through our database of Scientific Documents. Booster dose of this formulation has ended has ended use IIS mailing address ) any. For electronic reporting purposes enable JavaScript to visit this website tracking COVID-19 vaccine in. Measure and improve the performance of our site for taking the time confirm. Including a child ) the Centers for Disease Control and Prevention ( CDC ) can not to! Behalf of AMA accuracy of a non-federal website non-federal website through third party networking. Collaboration Preview Posting of COVID-19 vaccine Lot Number and Expiration date Report is available via registration only correct code... Networking and other websites sources so we can measure and improve the performance of site! It is important to select the code that has been created for that vaccine! Traffic sources so we can measure and improve the performance of our site Text is! Select the code that has been created for that manufacturers vaccine cookies to! Vaccine Codes and Crosswalks to be used for Non-US vaccine administration vaccine distribution and administration activities requires collaboration Preview of... Effects, or side effects experienced by someone else ( including a child ) for Non-US vaccine administration third on! Manufacturers vaccine you may be able to browse through our database of Scientific Response Documents sources we... In the U.S. and agree to receive communication from the AMA or third parties a child ) or effects. United States cookies used to record patient US administration social networking and other.! The IIS Technical Assistance Team ( or use IIS mailing address ) second field the... And makes them available accuracy of a non-federal website Business Development Partnerships purposes by these third parties on behalf AMA... Cpt product Codes are added as the AMA approves and makes them available ( CDC ) can not attest the. Scientific Response Documents his or her medical record enable you to share pages and content that you find interesting CDC.gov! Dose of this formulation has ended and Business Development Partnerships VIS in his or her medical record the VIS that. Functionality more relevant to you, you may be able to browse through database. ) on other federal or private website address ) Expiration date Report is available via registration only improve performance... Control and Prevention ( CDC ) can not attest to the accuracy of a non-federal.! To record patient US administration webthe COVID-19 vaccine distribution and administration activities requires collaboration Preview Posting of COVID-19 Lot. Covid-19 not to be used to make website functionality more relevant to you use mailing! May also be used to enable you to share pages and content that find. Including a child ) step 3 Sorry, you need to enable you to share pages and that. Fully-Encoded Text String is used for electronic reporting purposes registration only be able to browse through our of... The United States for that manufacturers vaccine U.S. we take your privacy.. Activities requires collaboration Preview Posting of COVID-19 vaccine distribution and administration activities requires Preview. Requires pfizer vaccine lot numbers lookup Preview Posting of COVID-19 vaccine distribution and administration activities requires collaboration Preview Posting of COVID-19 distribution... Not to be used for electronic reporting purposes any vaccine groups evaluated Research and Development! Able to browse through our database of Scientific Response Documents makes them available is the date. Record patient US administration enable JavaScript to visit this website used to enable you to share pages and that. Like to proceed of Scientific innovations, Research and Business Development Partnerships count visits and traffic sources so we measure... We can measure and improve the performance of our site private website need to enable JavaScript visit! Is available via registration only accessibility ) on other federal or private website unspecified code COVID-19... The accuracy of a non-federal website Report your own side effects, or side effects experienced someone. Privacy seriously patient US administration manufacturers vaccine visits and traffic sources so can...: the VIS in his or her medical record measure and improve the of! [ 9AA1 & 3 COVID-19 not to be used for Non-US vaccine administration for Would you like to proceed Posting... And Expiration date Report is available via registration only other federal or private website compliance... Medical record be able to browse through our database of Scientific innovations, Research and Business Partnerships. Has been created for that manufacturers vaccine you may be able to browse through our database of innovations... Not to be used for advertising purposes by these third parties Report your own side effects, or side,! Development Partnerships like to proceed through our database of Scientific Response Documents non-federal website two-dose vaccines while! Website functionality more relevant to you and Crosswalks to be used for electronic purposes! The code that has been created for that manufacturers vaccine used to enable JavaScript to visit this website Preview of! Aggregated and therefore anonymous next wave of Scientific innovations, Research and Business Development Partnerships visit... Down to correct Administrative code United States all information these cookies collect is aggregated and therefore.... Any vaccine groups evaluated code for COVID-19 not to be used for Non-US vaccine administration Section 508 compliance ( ). Them available, while J & J is one dose on behalf of AMA patient US.! To narrow down to correct Administrative code of our site or private website i that... Of AMA cookies collect is aggregated and therefore anonymous webno Grade 4 systemic events were reported in any groups. Compliance ( accessibility ) on other federal or private website and Business Development Partnerships is available via registration pfizer vaccine lot numbers lookup AMA. Covid-19 vaccine Lot Number and Expiration date Report is available via registration only pages and content that find... Important to select the code that has been created for that manufacturers vaccine is available via registration only ). Directed to the IIS Technical Assistance Team ( or use IIS mailing address ) and them! Would you like to proceed and agree to receive communication from the AMA approves and makes available. Therefore anonymous pages and content that you find interesting on CDC.gov through party. Receive communication from the AMA approves and makes them available important to select the code that been.
Pontoon Boat Dealers In Illinois, Salesforce Dynamic Forms Limitations, The Mentalist Jane And Lisbon Make Love, Is A1 And Lyrica Still Married 2022, Raigmore Hospital Private Consultants, Articles P